Philips, Janssen Join to Cure Neuropsychiatric Disorders - Analyst Blog
Healthcare, consumer lifestyle and lighting giant Koninklijke Philips N.V. PHG recently inked a multi-year development agreement with the leading pharmaceutical company Janssen Pharmaceutica N.V. The collaboration aims at developing an innovative, handheld blood test that will help doctors break new grounds in areas of neuropsychiatric disorders.
Per the agreement, Philips’ Minicare system, currently under development, will be responsible for manufacturing and developing the handheld blood test once it is completed. Janssen, on the other hand, will conduct clinical studies which will help in the validation of results before they can be used for commercial purposes.
Philip’s management remains bullish regarding the competence of its latest proprietary biosensor technology, Minicare I -20 system, which is equipped with handheld analyzer, highly efficient software and a single-use disposable cartridge. Extremely advanced, the system can easily sense several target molecules in blood samples at low concentrations and display the results on the analyzer in minutes.
Integrating Philips’ profound expertise in point-of-care testing and applications monitoring with Jansen’s key strength of developing innovative neuroscience solutions, the recent tie-up aspires to create a productive solution for treating brain disorders. Philips believes that the highly flexible Minicare system can be tailored according to a broad spectrum of pharmaceutical needs.
We believe the latest deal will strengthen Philips’ position in the healthcare market. Breakthrough innovations in neuropsychiatric disorders will make the treatments infinitely better, opening up huge commercial possibilities. This, in turn, indicates bright prospects for Philips, which is well positioned to foster such innovative inventions going forward.
Phillips currently has a Zacks Rank #5 (Strong Sell). Better-ranked stocks in the sector include Universal Electronics Inc. UEIC, Whirlpool Corp. WHR and Samsung Electronics Co. Ltd. SSNLF. All three stocks hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
KONINKLIJKE PHL (PHG): Free Stock Analysis Report
WHIRLPOOL CORP (WHR): Free Stock Analysis Report
UNIVL ELECTRS (UEIC): Free Stock Analysis Report
SAMSUNG ELE LTD (SSNLF): Get Free Report
To read this article on Zacks.com click here.
Zacks Investment Research
